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Increased incidence of specific acute cardio-
vascular outcomes, including myocardial
infarction, ventricular arrhythmia, episodes of
atrial fibrillation, ischemic stroke, and heart
failure (HF), have been reported to occur
immediately after as little as 1–2 hr of
increased particulate matter (PM) concentra-
tion (Peters et al. 2001; Rich et al. 2006b), as
well as 1–2 days later (Burnett et al. 1999;
D’Ippoliti et al. 2003; Morris and Naumova
1998; Morris et al. 1995; Peters et al. 2000,
2005; Rich et al. 2005, 2006a; Schwartz and
Morris 1995; Symons et al. 2006; Wellenius
et al. 2005a, 2005b, 2006; Wong et al. 1999;
Zanobetti and Schwartz 2005). However, not
all studies have reported these acute to suba-
cute responses (Levy et al. 2001; Rich et al.
2004; Sullivan et al. 2005; Vedal et al. 2004).
Recent epidemiologic, animal, and controlled
human exposure studies have suggested that
PM air pollution may elicit changes in sub-
clinical indices, such as autonomic function,
inflammation, endothelial dysfunction, and
thrombotic tendency within hours after air
pollution exposures, which may contribute to
the increased incidence of cardiovascular
disease observed (Brook et al. 2002; Gold
et al. 2000; Liao et al. 1999; Magari et al.
2001, 2002; Mills et al. 2005, 2007; Nemmar
et al. 2002, 2003; Riediker et al. 2004;
Ruckerl et al. 2006; Tornqvist et al. 2007;
Tunnicliffe et al. 2001; Wellenius et al. 2003).
Wellenius et al. (2005a) reported small but
statistically signiﬁcant increases in the risk of
HF hospital admissions associated with
increases in same-day PM10 and nitrogen diox-
ide concentration in Pittsburgh, Pennsylvania.
In a later multicity study, these same investi-
gators reported a 0.72% [95% confidence
interval (CI), 0.35–1.10%] increase in risk of
HF admission for each 10-μg/m3 increase in
same-day ambient PM10 concentration
(Wellenius et al. 2006). These Medicare data-
base admission studies demonstrated acute
cardiovascular responses to air pollution that
require an exploration of possible physiologic
correlates both for veriﬁcation and for clues as
to mechanism. We hypothesized that hospital
admissions for decompensation of HF that
were triggered by air pollution would be asso-
ciated with more frequent subclinical
increases in pulmonary arterial (PA) diastolic
and right ventricular (RV) pressures. Such
pressure increases could ultimately lead to
emergency department/hospital admission
when individuals are vulnerable due to the
presence of other established HF exacerbation
triggers (e.g., volume overload, electrolyte sta-
tus, decreased oxygenation, rhythm distur-
bance, exertion, decreased myocardial
contractility, suboptimal medical therapy). If
PM has a causal role in HF admissions
because of acute pressure increases, then
direct passive measurement of these specific
pressures should be a much more sensitive
and upstream measure of stress on the car-
diopulmonary system than hospital admis-
sions for HF, which presumably depend on a
conﬂuence of exacerbating factors.
Therefore, we coupled passively moni-
tored data of continuous PA diastolic and RV
pressure data in HF patients implanted with
the Chronicle Implantable Hemodynamic
Monitor (Medtronic, Inc., Minneapolis,
MN) and ambient fine PM [aerodynamic
diameter ≤ 2.5 μm (PM2.5)] measurements
made at monitoring stations throughout New
Jersey. In this pilot study to investigate the
feasibility of such an approach to examine
mechanisms underlying previously reported
associations between air pollution and HF,
we examined the association between daily
mean PM2.5 concentrations and daily mean
PA and RV pressures.
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OBJECTIVES: We explored the association between acute changes in daily mean pulmonary artery
(PA) and right ventricular (RV) pressures and concentrations of ambient fine particulate matter
[PM with aerodynamic diameter ≤ 2.5 µm (PM2.5)] as an explanation for previous associations
between congestive heart failure (HF) hospital admissions and PM.
MATERIALS AND METHODS: In the Chronicle Offers Management to Patients with Advanced Signs
and Symptoms of Heart Failure (COMPASS-HF) trial, to see whether management of ambulatory
HF could be improved by providing continuous right heart pressure monitoring to physicians, the
Chronicle Implantable Hemodynamic Monitor (Medtronic, Inc., Minneapolis, MN, USA) contin-
uously measured multiple right heart hemodynamic parameters, heart rate, and activity trends in
subjects with moderate/severe HF. Using these trial data, we calculated daily mean pressures, using
only those time intervals where the subject was not physically active (n = 5,807 person-days; n = 11
subjects). We then studied the association between mean daily PA/RV pressures and mean ambient
PM2.5 concentrations on the same day and previous 6 days.
RESULTS: Each 11.62-µg/m3 increase in same-day mean PM2.5 concentration was associated with
small but significant increases in estimated PA diastolic pressure [0.19 mmHg; 95% confidence
interval (CI), 0.05–0.33] and RV diastolic pressure (0.23 mmHg; 95% CI, 0.11–0.34). Although
we saw considerable differences in the magnitude of response by COMPASS-HF randomization
group (total data access for physicians vs. blocked clinician access), season, left ventricular ejection
fraction, and obesity, these effects were not signiﬁcantly different.
CONCLUSIONS: These pilot study ﬁndings provide a potential mechanism for previous ﬁndings of
increased risk of HF associated with ambient PM. However, because of the small number of sub-
jects, a larger study is needed for conﬁrmation.
KEY WORDS: air pollution, diastolic, heart, pressure, pulmonary artery, right ventricle. Environ
Health Perspect 116:1167–1171 (2008). doi:10.1289/ehp.11230 available via http://dx.doi.org/
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Study population and outcomes. We studied
class III HF patients who were participating in
the COMPASS-HF (Chronicle Offers
Management to Patients with Advanced Signs
and Symptoms of Heart Failure) trial and
were implanted with the Chronicle at either
Robert Wood Johnson University Hospital in
New Brunswick, New Jersey, or Beth Israel
Medical Center in Newark, New Jersey (n =
13 subjects). In this trial, the Chronicle con-
tinuously measured and stored intracardiac
pressure, body temperature, physical activity,
and heart rate. This device has been described
in detail previously (Bourge et al. 2008).
Briefly, the device includes a programmable
unit similar to the pulse generator of a pace-
maker, and a transvenous lead with a sensor
near its tip to measure intracardiac pressures.
The device is positioned subcutaneously in the
pectoral area. The lead is placed transvenously
with its tip located in the RV outﬂow tract or
high septum. Approximately every 8 min, the
device stores the medians of several pressure
metrics, including estimated PA diastolic pres-
sure (ePAD), RV diastolic pressure, RV systolic
pressure, mean PA pressure (MPAP), physical
activity, and heart rate (beats per minute).
ePAD is deﬁned as the RV pressure at the time
of pulmonary valve opening and is correlated
(r = 0.84) with actual PA pressure (Magalski
et al. 2002; Ohlsson et al. 1995; Zile and
Brutsaert 2002). Physical activity level was
measured by an accelerometer in the chest wall
device. Any physical activity sensed by the
accelerometer is measured and averaged over
the programmed storage interval (i.e., 8 min).
A physical activity of 0 means that the sensor
did not detect any activity during that interval.
Each week, these measurements were
transmitted by patients via telephone line and
subsequently downloaded to each patient’s
cardiologist using the Internet. As part of the
COMPASS-HF trial, subjects were random-
ized subjects to either “total clinician access,”
which meant the cardiologist could view these
data weekly and, if necessary, prescribe
changes in medications or therapy, or
“blocked clinician access,” which meant the
cardiologist could not view these pressure
data and could monitor the subject only dur-
ing regularly scheduled clinic visits (i.e., the
normal standard of care). Details of this trial
have been published previously (Bourge et al.
2008). A barometric pressure monitor
(Chronicle Tracker, Medtronic, Inc.) worn by
the patient also made continuous measure-
ments and stored values for the same time
intervals as the heart pressure readings. As
part of the COMPASS-HF trial, ejection frac-
tion was obtained by standard clinical
echocardiography. Heart failure etiology was
based on clinical criteria. If there was known
coronary artery disease or history of myocar-
dial infarction, patients were categorized as
ischemic. Patients without these conditions
were categorized as non ischemic.
Of the original 13 study subjects implanted
with the Chronicle, we excluded one patient
who lived in New York because we could not
match a New Jersey air pollution monitor to
that person. We also excluded a second subject
who died of septic shock 24 days after device
implantation, leaving 11 subjects for analysis.
For each subject, we included all pressure data
from the date of implant through the date of
death or last data transmittal before 11 January
2007 [range, 358–1,090 days; median, 846
days (2.32 years)]. For our primary analysis
examining changes in daily pressure and daily
PM2.5 concentration, we excluded all intervals
where the subject’s physical activity was > 0
and then calculated mean PA and RV pressures
for each day of observation, leaving n = 5,807
person-days (n = 11 subjects) for analysis. The
University of Medicine and Dentistry of New
Jersey Institutional Review Board (New
Brunswick and Piscataway campuses) approved
this study.
PM and weather measurements. PM2.5 was
measured continuously in New Brunswick,
Camden, Elizabeth, Jersey City, and Rahway,
New Jersey, during the study period by the
New Jersey Department of Environmental
Protection (Trenton, NJ) using a tapered ele-
ment oscillating microbalance. We retrieved
hourly concentrations at these stations from
the U.S. Environmental Protection Agency
(EPA) website (U.S. EPA 2007). For each
subject, we calculated the distance between
each PM2.5 monitor and the subject’s resi-
dence, assigning PM2.5 measurements from
the closest monitor to their residence. We
assigned all subjects PM2.5 measurements
from either the New Brunswick or Elizabeth
monitoring sites (median distance, 13.4 km;
range, 7.0–34.2 km).
Temperature and dew point were meas-
ured hourly at the Newark, Caldwell,
Somerset, and Trenton airports during the
study period. We used the airport monitor
closest to each subject’s residence to provide
the weather observations for that subject dur-
ing the study period. For each day, we calcu-
lated apparent temperature (Kalkstein and
Valimont 1986; O’Neill et al. 2007; Steadman
1979; Zanobetti and Schwartz 2005) as a
measure of each subject’s perceived air temper-
ature given the humidity [apparent tempera-
ture = –2.653 + (0.994 × air temperature) +
(0.0153 × dewpoint2)] and used these values in
all analyses.
Statistical analysis. We used a two-step
modeling process to estimate the change in
daily mean ePAD associated with each incre-
mental increase in same-day (i.e., lag 0) mean
PM2.5 concentration. In the first step, each
subject appeared to have different long-term
patterns in ePAD during the follow-up period
(data not shown). Therefore, we removed
long-term trends in ePAD separately for each
person via spline-based nonparametric regres-
sion. We regressed a natural cubic spline
(3 degrees of freedom) of time against ePAD
and obtained residuals from this model to be
used as the outcome in the second step of the
analysis. We found that higher degrees of free-
dom were not necessary for modeling the
long-term trends and did not substantially
alter the results in the second step of the analy-
sis (data not shown). In the second step, focus-
ing on average short-term pressure changes
associated with same-day PM2.5 concentra-
tion, we used a repeated-measures model with
these residuals as the response, combining all
subjects’ data into a single model. We
regressed ﬁxed factors of same-day PM2.5 con-
centration, day of week, and month, as well as
quadratic effects of apparent temperature and
barometric pressure, against these residuals,
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Table 1. Characteristics of study population (n = 11). 
Age at Heart rate at Other implanted
ID no. Sex Race Height (m) Weight (kg) BMI (kg/m2) implant (years) HF etiology implant (bpm) LVEF at implant device
01 Female White 1.60 78.9 30.8 60 Ischemic 76 65 None
02 Female White 1.68 67.1 23.9 57 Nonischemic 71 20 None
03 Female White 1.60 97.5 38.1 33 Nonischemic 82 15 ICD
04 Female Hispanic 1.65 92.1 33.8 42 Nonischemic 84 40 None
05 Female Black 1.55 74.8 31.2 49 Nonischemic 48 45 None
06 Male White 1.83 88.4 26.4 65 Nonischemic 76 20 Bi-V ICD
07 Male White 1.70 92.1 31.8 67 Ischemic 80 40 ICD
08 Male White 1.75 117.9 38.4 61 Nonischemic 72 20 Bi-V ICD
09 Female Black 1.65 130.6 47.9 25 Nonischemic 94 15 ICD
10 Male White 1.73 73.9 24.8 53 Ischemic 84 35 ICD
11 Male White 1.75 100.2 32.6 68 Ischemic 56 22 ICDusing a first-order autocorrelation structure,
such that we modeled measurements separated
by d days to have a correlation of ρd, where ρ
represents the correlation between measure-
ments from 2 successive days. We then
repeated this procedure to examine separately
the changes in daily RV diastolic pressure, RV
systolic pressure, and MPAP associated with
each 11.62 μg/m3 increase (the interquartile
range observed during the study period) in
same-day mean PM2.5 concentration. Relative
to compound symmetry, we found the first-
order autocorrelation structure provided a bet-
ter ﬁt for the data as determined by Akaike’s
information criterion.
Next, to evaluate whether the assumption
of a linear exposure response function was
justified, we examined the concentration–
response using quintiles of PM2.5 and per-
formed a test of trend. Last, to evaluate
whether any association between daily right
heart pressure and same-day PM2.5 concentra-
tion was independent of previous days’ mean
PM2.5 concentrations, we repeated this two-
stage modeling process including the mean
PM2.5 concentrations from lag days 0–6,
rather than just lag 0, in the same model. For
each analysis, we present the unit change in
right heart pressure associated with each
11.62 μg/m3 increase in PM2.5 concentration,
and its 95% CI.
We also evaluated effect modification of
any pressure–PM2.5 association by random-
ization group (total clinician access vs.
blocked clinician access), left ventricular ejec-
tion fraction (LVEF) at implantation (≥ 45%
vs. < 45%), season (winter vs. summer), and
body mass index (BMI) at implantation
(obese, BMI ≥ 30, vs. nonobese, BMI < 30),
by adding an interaction term (effect modiﬁer
× PM2.5) to the mixed model described
above. We present the unit change in right
heart pressure associated with each 11.62
μg/m3 increase in PM2.5 concentration for
each category of each potential effect modi-
fier. We conducted all analyses using
SAS/STAT software, version 9.1.3 for
Windows (SAS Institute Inc., Cary, NC).
Results
Subjects were predominantly white (73%),
and obese (73% had BMI ≥ 30) and ranged in
age from 25 to 68 years (median, 57 years).
All but two subjects had LVEFs < 45% at
Chronicle implantation, and seven (64%) also
had an implantable cardioverter defibrillator
(ICD) or biventricular ICD (Bi-V ICD)
(Table 1). All subjects (n = 11) were taking
beta-blockers and diuretics during the study
period, with lower but substantial proportions
taking angiotensin converting enzyme
inhibitors (n = 9), amiodarone (n = 4), digoxin
(n = 8), anticoagulants (n = 6 ), aspirin (n = 6),
and antihyperlipidemia medications (n = 4).
We found significant increases in daily
mean ePAD and RV diastolic pressure, and
nonsigniﬁcant increases in daily mean RV sys-
tolic pressure and MPAP, associated with each
11.62-μg/m3 increase in same-day mean PM2.5
concentration, after adjusting for long-term
time trends, calendar month, weekday, and
apparent temperature (Table 2). Because we
found larger, signiﬁcant associations with ePAD
and RV diastolic pressure, we restricted all fur-
ther analyses to these pressure measurements.
Changes in RV diastolic pressure and
ePAD generally increased with quintiles of
PM2.5 (Figure 1), and the tests for trend were
statistically signiﬁcant for both pressures (RV
diastolic pressure, p < 0.001; ePAD, p =
0.006). When we included the mean PM2.5
concentrations for lag days 1–6 in the same
model, ePAD and RV diastolic pressure
increases associated with each 11.62-μg/m3
increase in same-day (lag 0) mean PM2.5 con-
centration were not substantially attenuated
and remained statistically significant (ePAD:
0.17 mmHg; 95% CI, 0.02–0.32; RV diastolic
pressure: 0.23 mmHg; 95% CI, 0.10–0.35)
(Figure 2).
We found no statistically signiﬁcant effect
modiﬁcation of the PM2.5–RV diastolic pres-
sure association by access randomization
group, LVEF at implantation, season, or BMI
at implantation (Table 3). However, the unit
change in RV diastolic pressure was largest for
the blocked clinician access randomization
group compared with the total clinician access
group, subjects with LVEF ≥ 45% at implan-
tation compared with subjects with LVEF
< 45%, winter versus summer person-days,
and obese subjects compared with nonobese
subjects (Table 3).
Discussion
In a pilot study using continuous PA and RV
pressures in 11 class III HF patients and ambi-
ent measurements of PM2.5 at nearby monitor-
ing stations, we observed small, but statistically
signiﬁcant increases in mean daily ePAD and
RV diastolic pressure (0.19 and 0.23 mmHg,
respectively) associated with each 11.62-μg/m3
increase in mean PM2.5 concentration on the
same day. These increases were not attenuated
when controlling for the previous 6 lag days of
mean PM2.5 concentration. Further, the con-
centration–response functions were generally
linear. However, we found no statistically sig-
niﬁcant effect modiﬁcation by access random-
ization group, LVEF at implantation, obesity,
or season. These findings add mechanistic
plausibility to previous studies’ reports of
increased hospital admissions for HF associated
with ambient PM concentrations in the previ-
ous few days (Burnett et al. 1999; Morris et al.
1995; Schwartz and Morris 1995; Symons
et al. 2006; Wellenius et al. 2005a, 2006).
The observed pattern of lag day response
(strongest effect on lag day 0, a negative effect
on lag day 1–3, and little change in pressure
for lag days 4–6) is a pattern similar to that
observed by Wellenius et al. (2006). In their
study of Medicare hospital admissions for
HF, they reported a 0.72% increase in the
risk of hospital admission for HF associated
with each 10-μg/m3 increase in PM10 on lag
day 0, a negative association on lag day 1, and
no association on lag days 2 and 3.
Ambient PM may trigger pathophysio-
logic mechanisms by several means, which
ultimately lead to acute exacerbation of HF.
These include direct depressant effects on the
Right heart pressure changes and ambient particles
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Table 2. Change in mean daily pressure (mmHg) per 11.62-µg/m3 increase in mean PM2.5 concentration on
the same day (n = 11 subjects).
No. of Change in 
Outcome person-days pressure (mmHg) 95% CI p-Value
ePAD 5,807 0.19 0.05 to 0.33 0.01
RV diastolic pressure 5,807 0.23 0.11 to 0.34 <0.001
RV systolic pressure 5,807 0.12 –0.07 to 0.31 0.23
MPAP 5,667 0.12 –0.05 to 0.28 0.16
Figure 1. Change in mean daily ePAD (mmHg) and RV
diastolic pressure (mmHg) per quintile of mean daily
PM2.5 concentration on lag day 0 (n = 11 subjects).
Error bars are 95% CIs. Tests for trend were statisti-
cally significant: RV diastolic pressure, p < 0.001;
ePAD, p= 0.006.
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123 4myocardium secondary to ischemia (Pekkanen
et al. 2002; Wellenius et al. 2003), arrhyth-
mia (Rich et al. 2005, 2006a), PA vasocon-
striction (observed in rodent models; Batalha
et al. 2002), and reduced alveolar ﬂuid clear-
ance (Mutlu et al. 2006). These nonischemic
mechanisms may be of particular importance
because most of our subjects did not have an
underlying ischemic mechanism for their HF
(n = 7). The ultimate effect of any of those
pathways would be an increase in right heart
pressures, leading to hospitalization if it is
ampliﬁed and prolonged without compensa-
tion or treatment. The pressure changes
resulting in a hospitalization for HF are cer-
tainly much greater than those observed on
average for these 11 subjects, perhaps between
one and two orders of magnitude. One possi-
ble explanation for the muted pressure
response to ambient PM2.5 in these 11 sub-
jects is better management, with state-of-the-
art medical therapy (a requirement of the
COMPASS-HF trial), than that received by
the population of Medicare patients examined
by Wellenius et al. (2006). Thus, our lack of
dramatic pressure changes does not negate the
likelihood that the small changes we observed
could trigger larger changes in an HF patient
more particularly prone to decompensation.
Ultimately, the small changes we observed
and the limited number of subjects in our
analysis suggest the need for further study in
larger panels/cohorts to validate RV pressure
increases as a mechanism for acute air pollu-
tion effects on HF exacerbations.
Although our study had strengths, including
passive continuous monitoring of PA and RV
pressures in moderate to severe HF patients, it
also had several limitations. First, exposure mis-
classiﬁcation was likely because we used ambient
measurements of PM2.5 to approximate each
subject’s exposure, rather than personal mea-
surements. However, because this exposure error
is likely nondifferential with respect to heart
pressure measurements, our reported effect esti-
mates are likely underestimates.
Second, it is possible that residual con-
founding by meteorology conditions or an
unmeasured confounder may be responsible
for the effects observed. However, that factor
would have to both be correlated with daily
mean PM2.5 concentrations measured at the
monitoring stations and increases in daily
mean PA and RV pressures in these 11 sub-
jects. Thus, it seems unlikely that other mete-
orologic conditions not correlated with those
included in our analysis (temperature, relative
humidity, and barometric pressure) or other
acutely time-varying, non-weather-related fac-
tors could explain the results observed.
Third, although we retained 5,807 per-
son-days in our analysis, these were among
only 11 subjects, resulting in reduced statisti-
cal power in our main analyses and even less
power in our assessment of effect modifica-
tion by subject specific characteristics (e.g.,
access randomization group, obesity, and
LVEF at implantation) and season. However,
although we found no statistically signiﬁcant
effect modification by these characteristics,
there were considerable differences in the
magnitude of response between each level of
these characteristics (e.g., total clinician access
vs. blocked clinician access, obese vs.
nonobese, LVEF ≥ 45% vs. LVEF < 45%,
winter vs. summer), suggesting that with a
larger sample size these differences may have
been statistically significant. The previously
reported associations between obesity and sus-
ceptibility to air pollution (Chen et al. 2007;
Zeka et al. 2006) as well as increased PM-
related health effects in winter time (Becker
et al. 2005) are consistent with our ﬁndings.
In this pilot study of the acute effects of
ambient PM2.5 concentrations on a likely pre-
cursor of hospital admissions for HF exacerba-
tion (PA and RV pressure increases), we
demonstrated the feasibility of linking ambi-
ent air pollution data to continuously mea-
sured right heart pressures in HF patients.
Further, we found signiﬁcant increases in daily
ePAD and RV diastolic pressure associated
with increases in same-day ambient PM pollu-
tion concentrations. We have planned conﬁr-
mation in a larger sample with more varied
geography and therefore likely different
sources and composition of PM. 
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